Teacher Retirement System of Texas Lowers Position in CVS Health Corporation $CVS

Teacher Retirement System of Texas decreased its stake in shares of CVS Health Corporation (NYSE:CVS) by 9.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 615,859 shares of the pharmacy operator’s stock after selling 67,128 shares during the quarter. Teacher Retirement System of Texas’ holdings in CVS Health were worth $48,875,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in CVS. Sei Investments Co. raised its stake in CVS Health by 17.4% during the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock valued at $62,474,000 after buying an additional 134,535 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock valued at $77,353,000 after buying an additional 13,329 shares during the last quarter. Treasurer of the State of North Carolina raised its stake in CVS Health by 1.3% during the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock valued at $40,358,000 after buying an additional 7,588 shares during the last quarter. HUB Investment Partners LLC raised its stake in CVS Health by 25.0% during the second quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 3,011 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in CVS Health by 8.0% during the second quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock valued at $111,017,000 after buying an additional 119,439 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent operating results and outlook support upside: analysts point to CVS’s Q4 beat, year?over?year revenue growth and management’s FY?2026 EPS guidance, giving some investors confidence in the company’s turnaround and value proposition. Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
• Positive Sentiment: Longer?term value case: recent commentary argues CVS looks attractively valued if its Optum-like integration and retail/primary care initiatives gain traction, which supports buy?and?hold investors. Is CVS Health the Ultimate Value Stock to Buy Right Now?
• Neutral Sentiment: Sector dynamics: UnitedHealth’s stronger guidance and ongoing debates over coverage for expensive obesity drugs are reshaping payer/provider economics; these broader moves can influence CVS’s PBM/insurer peers and competitive positioning but are not company?specific catalysts. UnitedHealth Boosts Profit Forecast Without Committing to Medicare Obesity Drug Coverage
• Negative Sentiment: State regulatory risk — Tennessee passed a bill targeting pharmacy ownership of PBMs; the law could force structural changes and has prompted CVS to warn it may close stores and pursue litigation, creating revenue, margin and execution uncertainty in a meaningful regional market. Legislation to ban pharmacies from owning PBMs heads to Gov. Lee’s desk, CVS Health may close Tenn. locations
• Negative Sentiment: CVS warns store closures and legal fight: management has publicly said the Tennessee law could lead to ~100 store closures and plans to challenge the statute in court — a short?term cost and reputation headwind that investors view as downside risk. Tennessee passes crackdown on pharmacy middlemen; CVS warns 100 stores could close, vows court fight
• Negative Sentiment: Primary care deal economics: reports indicate the Mass General Brigham partnership could raise annual care spending by roughly $40M, suggesting the company’s primary?care expansion may carry larger near?term cost pressure than modeled. Mass General Brigham, CVS Primary Care Deal Could Have a $40M Hidden Cost of Access

CVS Health Stock Down 1.3%

CVS Health stock opened at $76.38 on Thursday. The stock has a market cap of $97.89 billion, a PE ratio of 55.35, a price-to-earnings-growth ratio of 0.81 and a beta of 0.51. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15. The stock has a fifty day moving average of $76.01 and a 200 day moving average of $77.84.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 7.14 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend is Thursday, April 23rd. CVS Health’s payout ratio is currently 192.75%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. The Goldman Sachs Group boosted their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Wolfe Research decreased their price target on CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, March 2nd. TD Cowen restated a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Sanford C. Bernstein upgraded CVS Health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $91.00 to $94.00 in a research note on Thursday, March 12th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.